Oncology

The conference also meets a unique need for the Northern California Sacramento Valley to provide a group of networked and collaborating oncologists a forum to discuss the most recent developments in oncology care in the context of local treatment approaches, patient populations, and open clinical trials. The conference includes didactic sessions from national oncology leaders and case-based panel discussions involving academic and community oncologists.

Through open discussions we will have the opportunity to analyze the latest discoveries in genetics and epigenomics in lung cancer, including diagnosis, minimal residual disease (MRD), monitoring for recurrence, and assessment of therapeutic success with targeted therapy and immunotherapy.

Clinician scientists will present the results of ongoing clinical trials on targeted therapy including immune therapy, anti-angiogenic therapy and others. Novel genetic and imaging methods to assess the alteration of the tumor microenvironment for monitoring the effectiveness of therapeutic responses in both pre-clinical and clinical trials will be discussed. Different clinical challenges and benefits of new therapeutic avenues including cardio-oncology will be presented.

Discuss predictive markers in clinical use with cancer immunotherapies and their relevance to cancer immunotherapy approaches, Summarize recent updates in newly approved FDA immunotherapies and their impact on diagnostics, Describe the importance of pathological response evaluation and its correlation with outcomes, specifically in the neoadjuvant setting.

Utilize evidence-based screening and diagnostic techniques for prostate cancer more efficiently. Discuss effective management of treatment failure in prostate cancer to help reduce mortality. Describe the most recent approach to treating locally advanced and metastatic urologic disorders.

With a focus on quality and collaboration, the Society conducts workshops, conferences, and publishes research. Its international advisory board and partnerships with leading institutions ensure a global perspective and knowledge exchange.

The Kukuna meeting not only offers high-yield CME through very impactful, practical presentations from renowned speakers, but it also gives opportunities for invaluable connections and friendships with fellow radiation oncology peers. And you get to enjoy all of this in one of the most beautiful places in the world

Describe the epidemiology, pathophysiology, and risk factors associated with melanoma, squamous cell carcinoma, Merkel cell carcinoma, and other neoplasms involving the skin, Apply best practices in the diagnosis, evaluation, and classification of melanoma and other cutaneous malignancies, Integrate the latest medical therapies and surgical techniques into the care of patients with cutaneous malignancies.

Each conference will consist of case-based panel discussions featuring local, Hawaii-based faculty, moderated by key experts from the mainland United States. Participants will have the chance to bring best practices back to their clinics and interact with local colleagues, fostering a collaborative environment that enhances clinical practice and patient care.

Attendance at these conferences will level up your CV and prove helpful in future endeavors. Moreover, it will give an insight into where all the nations stand concerning advancements and recent trends in Pulmonary and Respiratory Medicine. An event full of socialization, opportunities, information, and specialists should not be missed.

From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.

Each year, ASCO features a presidential theme guiding the program.